A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction

Journal of Human Genetics

Volumn 52, Issue 3, 2007, Pages 220-229

  Ebana, Yusuke ^a,b   Ozaki, Kouichi ^a   Inoue, Katsumi ^c   Sato, Hiroshi ^d   Iida, Aritoshi ^a   Lwin, Htay ^a   Saito, Susumu ^a   Mizuno, Hiroya ^d   Takahashi, Atsushi ^a   Nakamura, Takahiro ^a   Miyamoto, Yoshinari ^a   Ikegawa, Shiro ^a   Odashiro, Keita ^c   Nobuyoshi, Masakiyo ^c   Kamatani, Naoyuki ^a   Hori, Masatsugu ^d   Isobe, Mitsuaki ^b   Nakamura, Yusuke ^a   Tanaka, Toshihiro ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Functional analysis; Linkage disequilibrium mapping; Myocardial infarction; Single nucleotide polymorphism markers

Indexed keywords

INTER ALPHA INHIBITOR 3 PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CHROMOSOME 3P; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALPHA-GLOBULINS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HAPLOTYPES; HUMANS; INTRONS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33847310251     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-006-0102-5     Document Type: Article

References (35)

1. Balduyck M, Albani D, Jourdain M, Mizon C, Tournoys A, Drobecq H, Fourrier F, Mizon J (2000) Inflammtion-induced systemic proteolysis of inter-α-inhibitor in plasma from patients with sepsis. J Lab Clin Med 135:188-198
2. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897
3. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P (1993) Distinct pattern of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 92:2408-2418
4. Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherosclerosis. Science 251:788-791
5. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
6. de la Motte CA, Hascall VC, Calabro A, Yen-Lieberman B, Strong SA (1999) Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I:C). J Biol Chem 274:30747-30755
7. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA (2003) Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid; polycytidylic acid. Am J Pathol 163:121-133
8. Fries E, Kaczmarczyk A (2003) Inter-α-inhibitor, hyaluronan and inflammation. Acta Biochim Pol 50:735-742
9. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503
10. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome project; identification of 190,562 genetic variations in the human genome. J Hum Genet 47:605-610
11. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SFA, Thorgeirsson G et al (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233-239
12. Ikeda S, Kurose K, Jinno H, Sai K, Ozawa S, Hasegawa R, Komamura K, Kotake T, Morishita H, Kamakura S et al (2005) Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol Genet Metab 86:314-319
13. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Saito S, Nakamura Y, Tanaka T (2006) Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet (in press)
14. 7B type in the H3 heavy chain of the inter-α-inhibitor family. Eur J Biochem 268:544-553
15. Libby P (2002) Atherosclerosis in inflammation. Nature 420:868-974
16. Marenberg EM, Risch N, Berkman LF, Floderus B, de Faire U (1996) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041-1046
17. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, Nagata I, Ando K, Nobuyoshi M, Hanyuu M, Komeda M, Yonehara S, Kita T (2001) Expression of SRPSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Artrioscler Thromb Vasc Biol 21:1796-1800
18. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H (2002) Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21:2914-2918
19. Ohnishi Y, Tanaka T, Yamada R, Suematsu K, Minami M, Fujii K, Hoki N, Kodama K, Nagata S, Hayashi T et al (2000) Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population. Hum Genet 106:288-292
20. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y (2001) A high-throughput SNP typing system for genomewide association studies. J Hum Genet 46:471-477
21. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y et al (2002) Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
22. Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M et al (2004) Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429:72-75
23. Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y, Takahashi A, Tsunoda T, Ikegawa S, Kamatani N, Hori M, Nakamura Y, Tanaka T (2006) A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 38:921-225
24. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
25. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A (1984) Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 4:793-801
26. Storey JD (2002) A direct approach to false discovery rate. J R Stat Soc Ser B 64:479-498
27. The International HapMap Consortium (2003) The International HapMap Project. Nature 426:789-796
28. Tsunoda T, Lathrop GM, Sekine A, Yamada R, Takahashi A, Ohnishi Y, Tanaka T, Nakamura Y (2004) Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome. Hum Mol Genet 13:1623-1632
29. Wang Q, Rao S, Shen GQ, Li L, Moliterno DJ, Newby LK, Rogers WJ, Cannata R, Zirzow E, Elston RC et al (2004) Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genomewide linkage analysis. Am J Hum Genet 74(2):262-271
30. Yamada R, Tanaka T, Unoki M, Nagai T, Sawada T, Ohnishi Y, Tsunoda T, Yukioka M, Maeda A, Suzuki K et al (2001) Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 68:674-685
31. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916-1923
32. Yingsung W, Zhuo L, Morgelin M, Yoneda M, Kida D, Watanabe H, Ishiguro N, Iwata H, Kimata K (2003) Molecular heterogeneity of the SHAP-hyaluronan complex. J Biol Chem 278:32710-32718
33. Zhang EY, Fu DJ, Pak YA, Stewart T, Mukhopadhyav N, Wrighton SA, Hillgeren KM (2004) Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586. J Pharmacol Exp Ther 310(2):437-445
34. Zhao M, Yoneda M, Ohashi Y, Kurono S, Iwata H, Ohnuki Y, Kimata K (1995) Evidence for the covalent binding of SHAP, heavy chains of inter-α-trypsin inhibitor, to hyaluronan. J Biol Chem 270:26657-26663
35. Zhuo L, Hascall VC, Kimata K (2004) Inter-α-trypsin inhitibor, a covalent protein-glycosaminoglycan-protein complex. J Biol Chem 279:38079-38082